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BACKGROUND: Candida albicans is regarded as the
leading of candidosis. However, Candida glabrata has
emerged as an important pathogen of oral mucosa,
occurring both singly or in mixed species infections, often
with C. albicans. Compared with C. albicans, little is
known about the role of C. glabrata in oral infection. The
aim of this study was to examine single and mixed species
infection of oral epithelium involving C. glabrata and
establish its ability to invade and damage tissue.
METHODS: A reconstituted human oral epithelium
(RHOE) was infected only with C. glabrata, or simulta-
neously with C. glabrata and C. albicans. The ability of
both species to invade the tissue was examined using
species specific peptide nucleic acid (PNA) probe
hybridization and confocal laser scanning microscopy.
Epithelial damage was assessed by measuring lactate
dehydrogenase (LDH) activity.
RESULTS: Candida glabrata strains were able to colonize
the RHOE, in a strain dependent manner. Candida glab-
rata single infection after 12 h, generally revealed no
invasion of the RHOE, which contrasted with extensive
tissue invasion demonstrated by C. albicans. Mixed infec-
tion showed that C. albicans enhanced the invasiveness of
C. glabrata, and led to increased LDH release by the
RHOE, which paralleled the observed histological dam-
age.
CONCLUSIONS: The results obtained demonstrating
enhanced invasion and increased tissue damage caused by
mixed C. glabrata and C. albicans infections have impor-
tant clinical significance and highlight the need to identify
Candida species involved in oral candidosis.
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Introduction
Candidosis is a frequent opportunistic infection in
immunocompromised individuals (1). Candida albicans
remains the main aetiological agent in oral candidosis,
accounting for 70–80% of isolates from oral mucosal
lesions (2, 3). However, in recent years, Candida glabrata
has emerged as a notable pathogenic agent of the oral
mucosa, either co-infecting with C. albicans (4–7), or
occurring in single species infections (2, 4–6). Further-
more, C. glabrata is the third most common cause of
mortality in hospitals (8). Candida glabrata exhibits
signiﬁcant diﬀerences from C. albicans, including rela-
tive physical size, morphological properties and bio-
chemistry. Candida glabrata yeasts are smaller (1–4 lm)
than C. albicans yeast (4–6 lm) and have a much
narrower spectrum of carbohydrate utilization (8).
Furthermore, in contrast to C. albicans, C. glabrata is
generally not polymorphic, and only occurs in the yeast
form within the oral cavity (8). One possible explanation
therefore for the relatively frequent occurrence of
co-infection of C. albicans and C. glabrata is that these
signiﬁcant diﬀerences limit the extent of inter-species
competition allowing the organisms to occupy similar
oral niches. Importantly, C. glabrata-associated oro-
pharyngeal candidosis in HIV and cancer patients tends
to be more severe and more diﬃcult to treat than
infections caused solely by C. albicans (5, 6, 9).
An understanding of the interactions between these
Candida species has signiﬁcance for the development of
strategies for oral candidosis management. This is
important since, although oral Candida infections are
not associated with mortality, they are a major cause of
morbidity, and trigger chronic pain or discomfort upon
mastication, which may limit nutritional intake in
immunocompromised or elderly individuals (5, 10). In
addition, oral carriage of Candida has also been
proposed to be a pre-disposing factor for systemic
infection in severely immunocompromised patients (11).
Fluorescent in situ hybridization (FISH) is rapidly
becoming established as a valuable research and
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diagnostic tool in molecular pathology laboratories,
having previously been used to detect and diﬀerentiate
microorganisms in histological sections (12–14). Peptide
nucleic acid (PNA) probes are synthetic equivalents of
nucleic acids where the phosphate–sugar polynucleotide
backbone has been substituted with a peptide polymer
which provides the basis for linking nucleobases. Unlike
DNA, the peptide backbone of PNA probes is not
charged and this oﬀers greater stability in nucleic acid-
probe hybridization. Furthermore, PNA probes are
more resistant to degradation from nuclease and prote-
ase activity. Given such advantages, it is not surprising
that PNA probes have emerged as valuable tools in the
study of infectious diseases and represent a new gener-
ation of therapy-directed diagnostics (14–16). To exem-
plify this, the Yeast Traﬃc Light PNA FISHTM (YTL;
AdvanDx, Inc., Woburn, MA, USA) system is a newly
developed and commercialized PNA probe kit for the
rapid detection and distinction of the ﬁve most common
and clinically relevant Candida species (17, 18).
Previously, a reconstituted human oral epithelium
(RHOE) was successfully used to investigate coloniza-
tion and infection of tissue by Candida (19–23). Coupled
with species speciﬁc PNA probes and confocal laser
scanning microscopy (CLSM), co-infection of RHOE
using C. glabrata and C. albicans can therefore be
readily examined. The aim of this study was to generate
single and mixed species infections of RHOE with
C. albicans and C. glabrata and ascertain the role of
C. glabrata in the infection using species speciﬁc PNA
probes, CLSM and lactose dehydrogenase (LDH)
activity (as a measure of tissue damage) in infected
tissue.
Materials and methods
Organisms
A total of six clinical isolates of C. glabrata, originally
recovered from the oral cavity (strains D1 and AE2),
vagina (strains 534784 and 585626) and urinary tract
(strains 562123 and 513100) were used in this study. A
reference strain of C. glabrata from the American Type
Culture Collection (ATCC 2001) was also included. Oral
isolates were obtained from the bioﬁlm group of the
Centre of Biological Engineering, Minho University
(Braga, Portugal). Strains isolated from urinary and
vaginal infections were kindly provided from the culture
collection of the Hospital of Sa˜o Marcos (Braga,
Portugal). An oral isolate of C. albicans (strain
324LA ⁄ 94) from the culture collection of Cardiﬀ Dental
School (Cardiﬀ, UK) was selected based on its ability to
invade RHOE (21). The identity of all isolates was
initially conﬁrmed by PCR-based sequencing using
speciﬁc primers (ITS1 and ITS4) for the 5.8S subunit
gene (24).
Growth conditions
For each experiment, isolates were cultured on Sabou-
raud Dextrose Agar (SDA) (Merck, Darmstadt,
Germany) for 48 h at 37C. Isolates were then subcul-
tured in Yeast Nitrogen Base medium (YNB; BD
Diagnostics, Cowley, UK) supplemented with 0.5%
glucose (w ⁄ v) for 12 h at 37C. After incubation, cells
were harvested by centrifugation and washed three times
with phosphate buﬀered saline (PBS; pH 7). The yeasts
were then enumerated using an Improved Neubauer
haemocytometer and adjusted to a concentration of
2 · 106 cells ⁄ml in MCDB-153 deﬁned medium
(Clonetics, San Diego, CA, USA).
Reconstituted human oral epithelium infection
To investigate in vitro single- and mixed species infection
of oral mucosa by C. glabrata and C. albicans strains, a
reconstituted human oral epithelium (RHOE) (human
keratinocytes derived from a squamous carcinoma of
the buccal mucosa, cell line TR 146, SkinEthic Labo-
ratories, Nice, France) model was used. RHOE tissue
inserts (0.5 cm2) were placed in 24-well tissue culture
plates with MCDB 153-deﬁned medium containing
5 lg ⁄ml insulin, 1.5 mM CaCl2, 25 ll ⁄ml gentamicin,
and 0.4 lg ⁄ml hydrocortisone, according to the manu-
facturer’s instructions. For single species infection, 1 ml
of standardized suspensions (2 · 106 cells ⁄ml) of C.
glabrata or C. albicans was placed directly onto the
RHOE tissue inserts. For mixed species infection, 500 ll
of C. glabrata (2 · 106 cells ⁄ml) was combined with
500 ll of C. albicans (2 · 106 cells ⁄ml) suspension and
this preparation placed onto the RHOE tissue inserts.
Control samples were inoculated with 1 ml of medium
devoid of Candida. Infected tissues were incubated at
37C in a 5% CO2 environment with saturated humidity
for 12 h. After 12 h incubation, the maintenance
medium was removed and the RHOE tissues rinsed
twice with PBS to remove non-adherent Candida cells.
The RHOE specimens were then ﬁxed in 2% (v ⁄ v, in
ultrapure water) paraformaldehyde for 24 h, at 4C and
embedded in paraﬃn wax using standard histological
techniques. Tissue sections (20 lm) were cut and placed
onto Histobond+ coated microscope slides (Raymond
A Lamb, East Sussex, UK), de-waxed and processed
through xylene, ethanol and water.
Peptide nucleic acid ﬂuorescent in situ hybridization
(PNA FISH)
The Yeast Traﬃc Light PNA FISHTM (YTL-PNA
FISH) kit was used to examine invasion of the RHOE
by C. glabrata and C. albicans. The Candida PNA FISH
assay was performed according to the manufacturer’s
instructions with some modiﬁcations (17, 18). Sections
of RHOE were prepared as described above and then
washed brieﬂy in pre-warmed 1 · wash solution.
Hybridization with PNA probes was performed using
1 drop of C. albicans ⁄C. glabrata PNA probe mixture
and the overlay incubated in the dark in a humidiﬁed
chamber for 90 min at 55C. After probe hybridization,
excess PNA probe was removed by immersion of the
slides into pre-warmed 1 · wash solution (55C) for
30 min. For nuclear staining, keratinocytes within the
RHOE sections were counterstained with Hoechst 33258
for 30 min at room temperature, before washing in 1 ·
wash solution. The preparation was then mounted using
Candida glabrata and Candida albicans co-infection
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Vectashield fade-retarding mountant (Vector Labora-
tories, Peterborough, UK).
Confocal laser scanner microscopy
Sections hybridized with PNA probes were observed by
CLSM using a Leica TCS SP2 AOBS spectral confocal
microscope (Leica, Wetzlar, Germany). The sections
were scanned through the full depth using appropriate
settings for single, double or triple channel ﬂuorescence
recordings. Fluorescein-labelled PNA was used for
detection of C. albicans (laser excitation line 492 nm
and emissions detected 520 nm), Tamara-labelled PNA
was used for detection of C. glabrata (laser excitation
line 565 nm and emissions detected 580 nm) and Hoe-
chst 33258 (laser excitation line 485 nm and emissions
detected 410–485 nm) for nuclear context of keratino-
cytes. For multi-channel recordings, ﬂuorochromes were
scanned sequentially to eliminate spectral overlap
between probes. Selected images were presented either
as single confocal optical sections or maximum intensity
type constructions. Candida glabrata and C. albicans
were identiﬁed by red and green colouration respec-
tively, whilst keratinocytes were depicted blue. All
experiments were performed in duplicate.
Lactate dehydrogenase activity
The release of LDH from RHOE into the culture
medium was used as a measure of epithelial cell damage.
The LDH concentration in the medium from control
and infected tissues was determined after 12 h using the
CytoTox-ONETM kit (Promega, Madison, WI, USA)
according to the manufacturer’s instructions. The LDH
activity of Candida cells in cell culture medium devoid of
tissue was subtracted from the LDH activity of the
tissue infected with yeasts. The LDH released during
single or co-infection with the diﬀerent C. glabrata
strains and C. albicans was then expressed in relation to
the untreated control tissue. All experiments were
performed in duplicate.
Statistical analysis
Results were compared using one-way analysis of
variance (ANOVA) by applying Levene’s test of homo-
geneity of variance and the Tukey multiple-comparisons
test, using SPSS software [SPSS 17 (Statistical Package
for the Social Sciences), Inc., Chicago, IL, USA]. All
tests were performed with a conﬁdence level of 95%.
Results
Candida glabrata and Candida albicans single species
RHOE infection
The ability of C. glabrata and C. albicans strains to
colonize and invade human oral epithelium was exam-
ined after 12 h of infection using the RHOE model.
Results showed that all strains colonized the RHOE
surface, although the extent of colonization was highly
strain dependent (Table 1 and Fig. 1). Candida glabrata
534784 and 585626 (both vaginal strains) and C.
albicans exhibited the highest level of RHOE coloniza-
tion, whilst C. glabrata D1 and AE2 (both oral strains)
and 562123 (urinary isolate) colonized the tissue to a
lower extent (Fig. 1).
In general, after 12 h of infection, only clusters of
C. glabrata yeast were detected at the surface of the
keratinocyte layers (Fig. 1A,B). Furthermore, strains of
C. glabrata were generally unable to invade the epithe-
lium, although C. glabrata 513100 (urinary isolate), was
found within the upper (second or third epithelial cell
layer) region of the RHOE (Fig. 1B). In contrast, C.
albicans showed a greater ability to invade the RHOE
with hyphal elements completely penetrating all the
epithelial layers (Fig. 1D).
Histological examination of the RHOE after infection
with C. albicans, demonstrated noticeable changes
(Fig. 1D) compared with tissue infected with C. glabrata
(Fig. 1A–C). It was evident that C. albicans RHOE
infection induced superﬁcial detachment of keratinocyte
layers (Fig. 1D).
In order to quantify tissue damage, the levels of LDH
released by epithelial cells after infection were measured
(Fig. 2) and this showed that infection with C. albicans
produced higher relative levels of LDH activity
(P < 0.05) compared with C. glabrata strains. Further-
more, a moderate but statistically signiﬁcant increase in
relative LDH activity levels was induced by C. glabrata
strains compared with uninfected controls (P < 0.05).
Statistical diﬀerences with respect to LDH activity
released from the RHOE were not evident for
C. glabrata RHOE infection (P > 0.05).
Candida glabrata and Candida albicans RHOE mixed
species infection
Tissues simultaneously infected with C. glabrata and
C. albicans were subjected to appropriate histological
procedures, and the Candida species diﬀerentiated by
hybridization with speciﬁc C. glabrata ⁄C. albicans PNA
probes. The relative pattern of infection and ability to
invade the RHOE was then observed by CLSM.
Contrary to C. glabrata single species infection (Fig. 1
and Table 1), when co-infected with C. albicans, the
majority of C. glabrata strains were found to invade the
RHOE (Fig. 3 and Table 1). Yeast of oral isolates
(C. glabrataD1 andAE2), the urinary isolate (C. glabrata
Table 1 Candida glabrata and C. albicans single and co-infection
proﬁle of reconstituted human oral epithelium (at 12 h), as assessed
using confocal laser scanning microscopy and peptide nucleic acid
probe hybridization
Candida Origin
Single infection Co-infection
Colonization Invasion Invasion
C. glabrata (D1) Oral + None Moderate
C. glabrata (AE2) + None Moderate
C. glabrata (562123) Urinary + None Moderate
C. glabrata (513100) ++ Moderate High
C. glabrata (534784) Vaginal +++ None Moderate
C. glabrata (585626) +++ None High
C. glabrata
(ATCC 2001)
Reference ++ None High
C. albicans
(324LA ⁄ 94)
Oral +++ High –
Candida glabrata and Candida albicans co-infection
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562123) and the vaginal isolate (C. glabrata 534784)
penetrated to the third epithelial layer of the RHOE
(Fig. 3A). In the case of C. glabrata 513100 (urinary
isolate), C. glabrata 585626 (vaginal isolate) and the
reference strain (C. glabrata ATCC 2001) penetration to
the lowest epithelium layers (Fig. 3B) was evident.
Within the tissue, C. glabrata yeast were localized close
to vacuolized tissue portions (Fig. 4A) and observed
in close proximity to C. albicans hyphal elements
(Fig. 4B,C).
For several strains, the LDH levels released by the
RHOE epithelial cells infected by both species increased
signiﬁcantly compared to single species infection
(Fig. 2). Speciﬁcally, for tissues co-infected with
C. albicans and the oral isolates (C. glabrata D1 and
AE2), the vaginal isolate C. glabrata 585626 and the
A B
C D
Figure 1 Confocal laser scanner microscopy of Candida strains after 12 h of RHOE single infection, using YTL PNA FISHTM. C. glabrata cells
appear red, C. albicans are green, and keratinocytes nuclei are blue. (A) C. glabrata D1 showing sparse colonization (+) and no invasion; (B) C.
glabrata 513100 showing moderate colonization (++) and moderate invasion; (C) C. glabrata 534784 showing extensive colonization (+++) and
no invasion; (D) C. albicans showing extensive colonization (+++) and high invasion.
Figure 2 Relative lactate dehydrogenase (LDH) activities measured in the RHOE supernatant after 12 h of single infection ( ) and co-infection
( ) with C. glabrata and C. albicans. Control was performed without Candida cells. Error bars represent standard deviation. *LDH activity of
Candida albicans single infection is statistically diﬀerent from C. glabrata strains single infections (P < 0.05). **LDH activity of co-infection is
statistically diﬀerent from the respective single infection by each C. glabrata strain (P < 0.05). §LDH activity of C. albicans single infection is
statistically diﬀerent from co-infection values (P < 0.05).
Candida glabrata and Candida albicans co-infection
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reference strain (C. glabrata ATCC 2001) the levels of
LDH increased approximately two-fold, whilst a slightly
lower (1.5-fold) increase was evident with C. glabrata
562123 (urinary isolate). This increase in LDH activity
was found to be signiﬁcant (P < 0.05). However, no
statistically diﬀerences were found in the LDH activity
released by single and co-infection of C. glabrata 513100
(urinary isolate) and C. glabrata 534784 (vaginal
isolate). Furthermore, an increase in the levels of LDH
activity was veriﬁed between C. albicans single infection
and co-infection concerning both oral isolates (C.
glabrata D1 and AE2), one vaginal isolate (C. glabrata
585626), one urinary isolate (C. glabrata 562123) and
the reference strain (C. glabrata ATCC 2001)
(P < 0.05). This augment in activity was not found
for C. albicans co-infecting with one urinary isolate (C.
glabrata 513100) and one vaginal isolate (C. glabrata
534784) (P > 0.05).
Discussion
Although C. albicans is the most frequently encountered
pathogen (2, 3), several other species, and especially C.
glabrata, have recently emerged as oral pathogens (5–7).
Candida glabrata is unable to grow in ﬁlamentous forms
and is therefore only seen as relatively small yeast cells in
humans (8). In contrast, C. albicans is polymorphic
being able to grow as yeast, pseudohyphae and hyphae
A B
Figure 3 Single (A) and co-infection (B) of C. glabrata and C. albicans of RHOE after 12 h, assessed by CLSM and YTL PNA FISHTM.
C. glabrata cells appear red, C. albicans green, and keratinocytes nucleus blue. Candida glabrata AE2 presents moderate invasion while C. glabrata
ATCC 2001 presents high invasion in the presence of C. albicans.
A B C
Figure 4 Candida glabrata ⁄Candida albicans co-infection of RHOE after 12 h, assessed by CLSM and YTL PNA FISHTM. Panel A shows the
presence of C. glabrata yeast at a vacuolized tissue portion (see arrow), panel B illustrates shows C. glabrata cells near C. albicans hyphal elements
(see arrow) and panel C shows the adhesion and co-aggregation of C. glabrata cells on hyphal forms of C. albicans (see arrow).
Candida glabrata and Candida albicans co-infection
Silva et al.
425
J Oral Pathol Med
(25). In terms of tissue invasion, the ability of C. albicans
to generate hyphae is seen as advantageous as such
ﬁlamentous growth enables migration of the fungal
element from the point of adherence. Thigmotropic
movement is also a property of Candida hyphae (26)
which helps to promote invasion of the epithelium (14,
26, 27). The morphological diﬀerences and potentially
diﬀerent patterns of growth exhibited by C. albicans and
C. glabrata could allow these species to occupy the same
location within the oral cavity with limited competition
for space, thereby allowing co-existence in many
instances.
In recent years, C. albicans pathogenesis in mucosal
candidosis has been investigated by several authors (19–
21, 28) using RHOE as a surrogate model to animals.
Since mixed infection with both C. albicans and C.
glabrata species has often been reported in the mouth (5,
6), we aimed to examine for the ﬁrst time the eﬀect of
mixed infections in the RHOE model. This in turn
would indicate the possible pathogenic signiﬁcance of
mixed infection in the oral cavity.
Initially, the colonization patterns and invasion of
RHOE by several C. glabrata strains originating from
diﬀerent body sites were examined. The results obtained
(Table 1, Figs 1A–C and 3A) showed that the surface of
the RHOE was successfully colonized by all C. glabrata
strains tested, although this was noticeably strain
dependent. Furthermore, CLSM revealed that C. glab-
rata were generally unable to invade the RHOE (Fig. 2).
One exception was the urinary isolate C. glabrata
513100 which appeared to invade the superﬁcial epithe-
lial layers of the RHOE. These results highlight the
diversity of C. glabrata strains in colonization and
invasiveness capability, and mirror those previously
reported for C. parapsilosis (22) and C. albicans (21).
Schaller et al. (27) and Jayatilake et al. (20) have both
previously classiﬁed C. glabrata strains as being non-
invasive in RHOE infection.
It is important to note that six of the seven strains
analysed in this present study and classiﬁed as non-
invaders’ were sourced from diﬀerent body sites, possi-
bly indicating that strain origin is not an important
aspect in C. glabrata colonization and invasion of oral
epithelium. For example, the oral isolates (AE2 and D1)
exhibited a lower ability to colonize the RHOE, com-
pared with vaginal isolates (534784 and 585626).
Generally, most C. albicans isolates infecting the
RHOE model exhibit histological signs of hyphal
invasion (14, 19, 25, 27). This current study also
conﬁrmed the high invasiveness of C. albicans (Fig. 1D)
and particularly so when compared with C. glabrata
(Figs 1A–C and 3A). In fact, after 12 h of infection,
invasion of the RHOE by hyphal elements of C. albicans
was clearly evident, leading to marked disorganization
of RHOE and detachment of superﬁcial layers of the
tissue from the insert (Fig. 1D); this was in contrast to
the lower level of damage caused by C. glabrata strains
(Figs 1A–C and 3A). The extent of tissue damage was
quantitatively assessed by measurement of relative LDH
activity (Fig. 2). The results were in accordance with the
extent of Candida colonization and tissue damage
observed histologically (Fig. 1). The levels of LDH
released during single species infection was highest for
C. albicans which was expected given the previous
histological observations and considering that this
species is generally the most virulent (19, 27).
Interestingly, mixed species infection revealed
(Table 1 and Fig. 3B) that C. albicans promoted the
invasiveness of C. glabrata. In fact, all six C. glabrata
strains classiﬁed as non-invaders’ in single infection
studies were found to penetrate the oral epithelium in
the presence of C. albicans. It is known that C. albicans
hyphal formation is a critical determinant in invasive
pathogenesis especially in comparison with non-Candida
albicans Candida species, and it has been shown that C.
albicans with mutations in genes involved in promoting
hyphal development were less invasive than wild type
strains (20).
The exact mechanism of how C. albicans might
promote C. glabrata penetration of the oral epithelium
remains unclear. Damage to the integrity of the epithe-
lial surface caused by the growing tips of the C. albicans
hyphae (Fig. 4A,B) seems to provide access to lower
epithelial layers for C. glabrata yeast. In fact, C. glabrata
cells were observed in close proximity to C. albicans
hyphae and transported in this adhered form to deeper
tissue layers (Fig 4C, arrows). In this context, Ez-Azizi
et al. (29) showed the eﬃcient adherence of C. albicans
to a pre-formed C. glabrata bioﬁlm in a catheter model,
suggesting the co-aggregation of these two species
in vivo.
The increased LDH activity (Fig. 2) reported after
mixed infection with C. albicans and C. glabrata
supports a ﬁnding of enhanced pathogenicity (7). Of
additional concern is that strains of C. glabrata often
have higher resistance to azoles antifungal agents
compared with many other Candida species, including
C. albicans (5, 6, 30). In such instances, mixed infection
would not only exhibit enhanced pathogenicity (7), but
could also be more problematic to treat. Many diag-
nostic laboratories are limited in the identiﬁcation of
mixed Candida infection, particularly when non-diﬀer-
ential primary isolation agars such as Sabouraud
dextrose agar are used. The importance of recognizing
the occurrence of such mixed infection is however
highlighted by the results of this study and represents an
area that should be considered by both diagnostic
laboratories and clinicians alike.
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